Impact of Obesity on Survival Rates and Chemotherapy Efficacy in Stage IV Colorectal Cancer: A Retrospective Analysis - Takeaways - MDSpire

Impact of Obesity on Survival Rates and Chemotherapy Efficacy in Stage IV Colorectal Cancer: A Retrospective Analysis

  • By

  • Catherine G. Tran

  • Carine Dornbush

  • Braden S. Jensen

  • Sarah L. Mott

  • Elise E. H. Fannon

  • Austin C. Stark

  • Meghan E. Mali

  • Daniel J. Berg

  • Erin E. Talbert

  • Carlos H. F. Chan

  • February 5, 2026

  • 0 min

Share

  • 1

    Obesity is associated with a 1.3 times increased risk of developing stage IV colorectal cancer (CRC) and worsened prognosis in certain patient subgroups.

  • 2

    The study analyzed 320 patients with stage IV CRC, revealing median overall survival of 20.9 months, with no significant survival differences across BMI groups.

  • 3

    Obese patients had a higher likelihood of N2 disease compared to normal weight and overweight patients, indicating more advanced disease at diagnosis.

  • 4

    After adjusting for confounding factors, normal weight and overweight patients had increased risks of death compared to obese patients.

  • 5

    The study challenges the assumption that higher BMI negatively impacts survival in CRC, suggesting a potential 'obesity paradox' in cancer outcomes.

Original Source(s)

Related Content